Atlas Trials

Managed Access Programs for EXV811, Atrasentan

Clinical trial NCT07319585 · AVAILABLE

Trial details

NCT number
NCT07319585
Sponsor
Novartis Pharmaceuticals
Status
AVAILABLE
Study type
EXPANDED_ACCESS
IgA Nephropathy

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.